Triple Ring will be participating in the Women’s Health Innovation Summit from September 14-15, 2021 in Boston, MA. This summit focuses on accelerating innovation, investment, research and partnerships, and improving access to, and quality of healthcare for women worldwide.

Join us along with leading pharmaceutical companies, biotechs, medical device companies, start-ups, Femtech, insurers, CROs, investors, researchers, HCPs, and advocacy groups, to help drive innovation at the convergence of healthcare and technology. If you are in the area and would like to speak with our Business Development team, please reach out to us at info@tripleringtech.com.

Learn more at Women’s Health Innovation Summit.

Triple Ring will be exhibiting in the upcoming 13th Annual Next Generation Dx Summit in Washington DC, booth #305.

Xinyi Zhou, PHD, our Senior Systems Engineer will be discussing the challenges of Antimicrobial Susceptibility Testing and demonstrate a prototype device for AST testing with a simple colorimetric readout and a scalable design. Please check out the Presentation Agenda. 

The conference programs cover these areas:

To register and attend the event in-person or virtually, please visit Next Generation Dx Summit 2021.

Triple Ring’s CEO Joe Heanue will moderate the panel, “The Venture Studio: A New Model for Improving Medtech and Life Science Startup Success” at this week’s #LSI2021 Emerging Medtech Summit. The panel will feature Paul Conley, CEO, General Inception; Vikram Chaudhery, Principal, Genoa Ventures; and Ray Liu, CEO, Vena Vitals.
The panel takes place on Tues., May 11 at 1:17pm PST.

Digital representation of a human head silhouette with brain activity and binary code overlay.

Medical imaging is one of the most promising areas of research where advanced machine learning technologies can make a real difference in patient outcomes. Recent advances allow machine learning algorithms to correctly identify breast cancer from mammograms years before a radiologist can find the same cancers with the naked eye, as well as reduce the number of false positives that are costly for clinics and stressful for patients. But as with any new technology that deals with healthcare, there are regulations in place, designed to protect patients, which can slow the ability for innovative startups to bring their products to market. This field that is ripe for venture capital investment, but prospective investors should keep several things in mind as they evaluate investment opportunities. These include considerations around single-payer vs. multi-payer healthcare systems, variations in global regulatory environments, data privacy (HIPAA) laws, and more. In this presentation, we will discuss some of the most exciting advancements in medical imaging, as well as accelerators and inhibitors to bringing solutions to clinicians and their patients.

Images are licensed under Creative Commons License.

 

Triple Ring’s Walt Cecka, Sr. Director, Program Management will be moderating a panel discussion, Advancing Medical Device Innovation, for MassMEDIC’s November Town Hall meeting, on Thursday, November 12th, from 12:00 – 1:00 PM Eastern.

About the conversation:

Medical Devices are a key component of modern healthcare delivery, and like all technology-based industries, the field is undergoing rapid growth and evolution. Transforming nascent ideas through to fully adopted products requires innovation, collaboration, and creative investment strategies to efficiently bring breakthrough products to market.

A panel of experts from J&J Innovation Center, FUJIFILM Medical Systems, and Nihon Kohden Innovation Center will discuss the future of our industry, including:

Join us for a conversation about how startups can creatively bring true innovation to the medical device landscape, what impediments exist, and trends in investment.

Register Here

The Triple Ring team looks forward to meeting with innovative entrepreneurs at the upcoming Redefining Early Stage Investments (RESI) virtual conference, September 14-16.

The April 22, 2020 meeting of the US-Denmark MedTech Partnership Initiative in Palo Alto, California has been postponed. The current COVID19 pandemic is a serious public health threat and we are concerned about the safety and wellbeing of our participants as well as their friends and families.  We are still planning to host our meeting in Copenhagen during the 3rd week of September, 2020 and will send information related to this in the late Spring.

MedTech Strategist’s global investment & networking conference: Innovation Summit Dublin 2020

Note that this event has been rescheduled. The new dates are September 7 – 9 , 2020 at The Shelbourne Hotel, Dublin, Ireland

To our Clients and Partners: 

As we all continue to adapt to the evolving situation around the coronavirus, we would like to express our sincere hope that you and your families are safe and sound, and we’d like to give you an update regarding how Triple Ring is responding to the outbreak.

Like many companies, Triple Ring’s staff is now working almost entirely from their home offices or, in some cases, their garages. Given the nature of our business, our team is well-equipped to operate in a distributed fashion and, as a result, we have been able to continue focusing on our clients’ work with minimal interruption. The only change you are likely to notice is more home offices in the background on video calls, as well as the occasional dog barking during a meeting. Other than that, we are 100% open for business.

We are proud to say that many of our team members are working on projects that are directly related to COVID-19. In some cases those team members need to be on site and working in our labs. When this is necessary, we are taking every precaution to keep our staff safe and are closely following or exceeding CDC guidelines.

We encourage you to stay in touch and let us know how we can help you. You have our commitment that we will continue to do whatever we can to support our clients, partners, and employees during this situation and beyond.

We will all get through this. Together.

Thank you.

Joseph A Heanue, Ph.D.
President & CEO